Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 18,745 | 12,095 | 7,704 | 0 | 0 |
| Cost of Goods | 3,867 | 2,767 | 2,466 | N/A | N/A |
| Gross Profit | 14,878 | 9,328 | 5,238 | N/A | N/A |
| Operating Expenses | 51,876 | 40,762 | 46,259 | 49,283 | 52,898 |
| Operating Income | -36,131 | -30,667 | -40,555 | -49,283 | -52,898 |
| Other Income | 77 | 5 | 6 | 9 | 30 |
| Pre-tax Income | -36,054 | -30,662 | -40,549 | -49,274 | -52,868 |
| Income Tax | 279 | -118 | 1,014 | 210 | 789 |
| Net Income Continuous | -36,333 | -30,544 | -41,563 | -49,484 | -53,657 |
| Net Income | $-36,333 | $-30,544 | $-41,563 | $-49,484 | $-53,657 |
| EPS Basic Total Ops | -0.53 | -0.44 | -0.61 | -0.72 | -0.82 |
| EPS Basic Continuous Ops | -0.53 | -0.44 | -0.61 | -0.72 | -0.82 |
| EPS Diluted Total Ops | -0.53 | -0.44 | -0.61 | -0.72 | -0.82 |
| EPS Diluted Continuous Ops | -0.53 | -0.44 | -0.61 | -0.72 | -0.82 |
| EBITDA(a) | $-35,463 | $-30,009 | $-39,838 | $-48,971 | $-52,331 |